Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.09.2021 | Case report

Carboplatin/paclitaxel/trastuzumab

No therapeutic response: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Artac M, et al. Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases. Journal of Oncology Pharmacy Practice 20: 141-145, No. 2, Apr 2014. Available from: URL: http://doi.org/10.1177/1078155213480201 Artac M, et al. Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases. Journal of Oncology Pharmacy Practice 20: 141-145, No. 2, Apr 2014. Available from: URL: http://​doi.​org/​10.​1177/​1078155213480201​
Metadaten
Titel
Carboplatin/paclitaxel/trastuzumab
No therapeutic response: case report
Publikationsdatum
01.09.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-02044-z

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Ketorolac

Case report

Gemcitabine

Case report

Metoprolol

Case report

Antineoplastics